Inhibition of ER stress-associated IRE-1/XBP-1 pathway reduces leukemic cell survival.

@article{Tang2014InhibitionOE,
  title={Inhibition of ER stress-associated IRE-1/XBP-1 pathway reduces leukemic cell survival.},
  author={C. Tang and S. Ranatunga and Crystina L. Kriss and C. Cubitt and J. Tao and J. Pinilla-Ibarz and Juan R Del Valle and C. Hu},
  journal={The Journal of clinical investigation},
  year={2014},
  volume={124 6},
  pages={
          2585-98
        }
}
  • C. Tang, S. Ranatunga, +5 authors C. Hu
  • Published 2014
  • Biology, Medicine
  • The Journal of clinical investigation
    • Activation of the ER stress response is associated with malignant progression of B cell chronic lymphocytic leukemia (CLL). We developed a murine CLL model that lacks the ER stress-associated transcription factor XBP-1 in B cells and found that XBP-1 deficiency decelerates malignant progression of CLL-associated disease. XBP-1 deficiency resulted in acquisition of phenotypes that are disadvantageous for leukemic cell survival, including compromised BCR signaling capability and increased surface… CONTINUE READING
    View PDF
    106 Citations
    Highly Influencial Citations
    5
    Background Citations
    46
    Methods Citations
    8
    Results Citations
    3
    106 Citations
    Citation Type

    Citation Type

    Agonist-Mediated Activation of STING Induces Apoptosis in Malignant B Cells.
    • 107
    • PDF
    Loss of p 53 enhances the function of the endoplasmic reticulum through activation of the IRE 1 α / XBP 1 pathway
    • 2
    Development of Tumor-Targeting IRE-1 Inhibitors for B-cell Cancer Therapy
    Loss of p53 enhances the function of the endoplasmic reticulum through activation of the IRE1α/XBP1 pathway
    • 25
    • PDF
    Inhibition of the IRE-1α/XBP-1 pathway prevents chronic GVHD and preserves the GVL effect in mice.
    • 7
    • PDF
    Stimulation of surface IgM of chronic lymphocytic leukemia cells induces an unfolded protein response dependent on BTK and SYK.
    • 28
    • PDF
    Pharmacological targeting of MYC-regulated IRE1/XBP1 pathway suppresses MYC-driven breast cancer
    • 61
    • PDF
    IRE1α-XBP1s pathway promotes prostate cancer by activating c-MYC signaling
    • 39
    • PDF
    Molecular Pathways: Immunosuppressive Roles of IRE1α-XBP1 Signaling in Dendritic Cells of the Tumor Microenvironment
    • 15
    • Highly Influenced
    • PDF
    Targeting of BCR-ABL1 and IRE1α induces synthetic lethality in Philadelphia-positive acute lymphoblastic leukemia.

    References

    SHOWING 1-10 OF 40 REFERENCES
    Overexpression of TCL1 activates the endoplasmic reticulum stress response: a novel mechanism of leukemic progression in mice.
    • 50
    Blockade of XBP1 splicing by inhibition of IRE1α is a promising therapeutic option in multiple myeloma.
    • 280
    • PDF
    S1P1 expression is controlled by the pro-oxidant activity of p66Shc and is impaired in B-CLL patients with unfavorable prognosis.
    • 34
    • PDF
    XBP-1 regulates signal transduction, transcription factors and bone marrow colonization in B cells
    • 159
    • PDF
    The Differentiation and Stress Response Factor XBP-1 Drives Multiple Myeloma Pathogenesis
    • 343
    Synthesis of Novel Tricyclic Chromenone-Based Inhibitors of IRE-1 RNase Activity
    • 21
    17-DMAG targets the nuclear factor-kappaB family of proteins to induce apoptosis in chronic lymphocytic leukemia: clinical implications of HSP90 inhibition.
    • 93
    Selective inhibitors of nuclear export show that CRM1/XPO1 is a target in chronic lymphocytic leukemia.
    • 207
    • PDF
    The Bruton tyrosine kinase inhibitor PCI-32765 thwarts chronic lymphocytic leukemia cell survival and tissue homing in vitro and in vivo.
    • 524
    The B-cell receptor signaling pathway as a therapeutic target in CLL.
    • 318
    • PDF